125 mg and 250 mg tablets
Indications and Usage:
Gris-PEG is indicated for the treatment of dermatophyte infections such as tinea pedis, tinea corporis, tinea cruris, tinea unguium, tinea barbae, and tinea capitis. As there are considerable associated risks, the use of Gris-PEG is not indicated for trivial, superficial dermatophyte infections in which the use of antifungals alone would suffice.
Side Effects and Contraindications:
Gris-PEG is contraindicated in patients with porphyria or liver failure, and in pregnant women or women of childbearing potential. Males on Gris-PEG should wait 6 months before fathering children. Patients on concurrent coumadin (warfarin) therapy will need adjustment of the dosing of the medication. The most common side effects are hypersensitivity reactions and should prompt discontinuation of the drug. Occasionally the following side effects are reported: oral thrush, nausea, vomiting, epigastric distress, diarrhea, headache, fatigue, dizziness, insomnia, mental confusion, and impairment of performance of routine activities.
Pedinol Pharmacal Inc.